Product Information

CEFPROZIL 125 MG/5 ML SUSP is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1055 per ML under NDC 57237003401. Its NADAC has been published 659 times since Apr 9, 2014.

FDA first approved this application on Jan 30, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CEFPROZIL 125 MG/5 ML SUSP

Cefprozil
$0.1055per ML

Strength

125 mg/5mL

NDC

57237003401

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CEFPROZIL

Approval Type

Generic (ANDA)

FDA Application

ANDA065381

FDA Approved

1/30/2007

TE Code

AB

On Market Since

1/30/2007

Price Statistics

The NADAC for CEFPROZIL 125 MG/5 ML SUSP has been published 659 times since Apr 9, 2014, and over the history we have for it it has declined 65.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1055 per ML
All-time high$0.3071 (Feb 11, 2015)
All-time low$0.0917 (Jan 18, 2023)
52-week high$0.1195
52-week low$0.0986
Median price$0.1708
Average price$0.1926
Largest weekly change+73.0% (May 18, 2022)
Weeks tracked659
Tracking sinceApr 9, 2014

Price History

1W

-2.0%

1M

+0.6%

3M

-0.6%

6M

-8.5%

1Y

-15.2%

3Y

-32.3%

5Y

-59.1%

All

-65.6%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CEFPROZIL 125 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for CEFPROZIL 125 MG/5 ML SUSP, manufactured by Rising Pharma Holdings Inc., is $0.1055 per ML (NDC 57237003401), effective Nov 18, 2026.

How has the price of CEFPROZIL 125 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for CEFPROZIL 125 MG/5 ML SUSP has declined 65.6%. It has been tracked across 659 weekly CMS publications since Apr 9, 2014.

What are the highest and lowest recorded NADAC prices for CEFPROZIL 125 MG/5 ML SUSP?

Since Apr 9, 2014, the NADAC for CEFPROZIL 125 MG/5 ML SUSP has ranged from a low of $0.0917 (Jan 18, 2023) to a high of $0.3071 (Feb 11, 2015), with a median of $0.1708 per ML.

Are there cheaper alternatives to CEFPROZIL 125 MG/5 ML SUSP?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CEFPROZIL 125 MG/5 ML SUSP, is $0.0943 per ML — about 11% below CEFPROZIL 125 MG/5 ML SUSP.

Who manufactures CEFPROZIL 125 MG/5 ML SUSP?

CEFPROZIL 125 MG/5 ML SUSP (NDC 57237003401) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.